| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $18,263,136 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UM1AI069452 | A-Z Clinical Trials Unit | 000 | 20 | NIH | 12/8/2025 | $922,744 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG061800 | Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease | 000 | 7 | NIH | 1/23/2026 | $690,416 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K24AI125685 | Midcareer Mentoring Award for Patient-Oriented Research in Chlamydia trachomatis Infection | 000 | 9 | NIH | 2/2/2026 | $151,812 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01HL163249 | Silent Zones of Lung Disease in COPD | 000 | 4 | NIH | 1/30/2026 | $169,357 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01CA296932 | Evaluating the implementation and impact of standard-of-care delivered oncology financial navigation | 000 | 2 | NIH | 1/29/2026 | $171,954 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01AG086063 | A Pilot Trial of High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Older Adults with HIV. | 000 | 3 | NIH | 2/11/2026 | $125,982 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31DK139684 | Role of hemopexin in the development of urologicchronic pelvic pain syndrome | 000 | 2 | NIH | 1/30/2026 | $40,556 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31ES034986 | Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies | 000 | 3 | NIH | 12/19/2025 | $52,692 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31HD114429 | Ontogeny and differentiation of uterine natural killer cells | 000 | 3 | NIH | 1/23/2026 | $49,538 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T9952104 | Value-Based Medical Student Education Training Program | 02 | 3 | HRSA | 2/4/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T9952104 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $1,175,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HD111059 | Examining the effects of live telehealth exercise training on cardiometabolic outcomes in wheelchair users | 000 | 4 | NIH | 1/19/2026 | $562,707 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK141552 | CDKN1A (p21) regulation of cyst growth | 000 | 2 | NIH | 12/15/2025 | $635,232 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134489 | Distinct Glycophenotypes with Abnormal Signaling Define a Subpopulation of B cells Responsible for Production of Galactose-Deficient IgA1, the Main Autoantigen in IgA Nephropathy | 000 | 4 | NIH | 12/17/2025 | $497,782 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK133539 | Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy | 000 | 4 | NIH | 1/30/2026 | $666,128 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK137784 | Comprehensive Analysis of Oxalate Homeostasis in Calcium Oxalate Kidney Stone Formers | 000 | 3 | NIH | 12/12/2025 | $648,892 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134402 | Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD | 000 | 4 | NIH | 12/17/2025 | $396,661 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134310 | Differentiating slow from rapidly progressive ADPKD by cell-specific mitochondrial and transcriptional profiles | 000 | 3 | NIH | 1/9/2026 | $489,684 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01EY026588 | Scleral Remodeling in Myopia | 000 | 9 | NIH | 1/30/2026 | $550,326 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES034846 | The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration | 001 | 3 | NIH | 1/13/2026 | $122,700 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES034846 | The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration | 000 | 3 | NIH | 12/19/2025 | $414,266 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA276190 | Follicular Regulatory T-cells Promote Cancer | 000 | 4 | NIH | 12/5/2025 | $339,450 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA295454 | Targeting melanoma promoting RNA modification pathway for melanoma therapy. | 000 | 2 | NIH | 12/16/2025 | $398,013 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA279849 | T cell-intrinsic metabolic control of radiotherapy | 000 | 3 | NIH | 2/6/2026 | $362,575 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DA061766 | Prefrontal circuits controlling heroin seeking | 001 | 2 | NIH | 2/6/2026 | $47,577 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DA061766 | Prefrontal circuits controlling heroin seeking | 000 | 2 | NIH | 1/28/2026 | $428,194 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK115752 | Injury Response Mediated Pathogenesis in Renal Ciliopathies | 000 | 8 | NIH | 12/15/2025 | $530,077 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR078342 | Social Determinants and Timeliness of Total Knee Replacement A National Perspective | 000 | 5 | NIH | 1/21/2026 | $440,499 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA259480 | MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia | 000 | 5 | NIH | 12/8/2025 | $310,541 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA258248 | Credentialing next-generation human glioma models for precision therapeutics | 000 | 5 | NIH | 12/22/2025 | $505,680 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269365 | ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation | 000 | 4 | NIH | 1/14/2026 | $305,724 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA265981 | A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancer | 000 | 5 | NIH | 1/26/2026 | $330,111 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG077395 | Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease | 000 | 4 | NIH | 12/11/2025 | $397,296 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG085793 | Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals | 000 | 2 | NIH | 12/3/2025 | $663,173 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR073004 | Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin | 000 | 7 | NIH | 12/24/2025 | $565,073 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR072697 | Nanoscale structure and function of desmosomes | 000 | 7 | NIH | 12/16/2025 | $362,180 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI170913 | Mechanism and targeting of inflammasome activation in lung inflammation and injury | 000 | 4 | NIH | 1/23/2026 | $571,095 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI164717 | Mechanisms Controlling the Development and Function of Intestinal Effector Treg cells | 000 | 4 | NIH | 1/16/2026 | $729,679 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R00CA277554 | Dissecting the Myeloid-Th17 axis in the pathogenesis of Colitis-associated Colorectal Cancer | 000 | 4 | NIH | 1/28/2026 | $224,039 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R37CA296615 | Quality of End-of-Life Care for Children with Cancer: A COG Observational Study | 000 | 2 | NIH | 2/12/2026 | $555,731 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM156375 | Mechanisms of Molecular Motors in Transcription and Protein Homeostasis | 000 | 2 | NIH | 1/8/2026 | $334,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R25CA278711 | The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program | 000 | 3 | NIH | 12/17/2025 | $291,600 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R25DK115353 | UAB KUH KURE | 000 | 8 | NIH | 2/5/2026 | $129,341 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21NS147535 | AMPA Receptor Function at Interneuron Synapses | 000 | 1 | NIH | 1/15/2026 | $186,250 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA297395 | Modifying the Single Domain Antibody Framework as Platform for Enhanced Radiotherapy | 000 | 2 | NIH | 2/11/2026 | $153,818 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21NS140497 | Dystrophin as a novel regulator of the circadian clock in skeletal muscle and the brain | 000 | 2 | NIH | 12/5/2025 | $187,316 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R03TR005967 | Molecular and therapeutic correction of XMEA using novel zebrafish and mouse models | 000 | 1 | NIH | 1/28/2026 | $149,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA296500 | RANK Signaling Inhibitors for Osteolytic Lesions in Multiple Myeloma | 000 | 2 | NIH | 1/26/2026 | $247,611 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG092916 | Cocoa to maximize exercise training in older adults - COMET Trial | 000 | 1 | NIH | 12/26/2025 | $409,750 |
|
